NCT02101788 2025-11-13Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity CancerNational Cancer Institute (NCI)Phase 2/3 Completed260 enrolled 20 charts
NCT03098030 2020-12-09Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung CancerUnited TherapeuticsPhase 2/3 Completed483 enrolled 19 charts